Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Prepaid Assets (2021 - 2026)

Zymeworks (ZYME) posted Prepaid Assets of $16.3 million for Q1 2026, up 6.18% sequentially from $15.3 million in Q4 2025, and down 1.85% YoY from $16.6 million in Q1 2025.

Analysis

Zymeworks (ZYME) Prepaid Assets (2021 - 2026) Analysis & Trends

Zymeworks has reported Prepaid Assets for 6 years, with the latest figure at $16.3 million in Q1 2026.

  • Quarterly Prepaid Assets fell 1.85% year-over-year to $16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (down 1.85% YoY) and the FY2025 annual result came in at $15.3 million, down 18.71% from the prior year.
  • Prepaid Assets improved to $16.3 million in Q1 2026 per ZYME's latest filing, from $15.3 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $31.4 million in Q2 2023 and troughed at $10.4 million in Q3 2025.
  • A 5-year average of $18.0 million and a median of $17.8 million in 2024 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2024 and 2025: Prepaid Assets jumped 91.26% in 2024, then sank 54.4% in 2025.
  • Over 5 years, Prepaid Assets stood at $19.1 million in 2022, then advanced by 0.25% to $19.1 million in 2023, then dropped by 1.37% to $18.9 million in 2024, then decreased by 18.71% to $15.3 million in 2025, then rose by 6.18% to $16.3 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $16.3 million, $15.3 million, and $10.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Zymeworks 2.13 Bn 1.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.76 Mn
Mar 31, 2026 16.28 Mn
Dec 31, 2025 15.33 Mn
Sep 30, 2025 10.43 Mn
Jun 30, 2025 12.12 Mn
Mar 31, 2025 16.59 Mn
Dec 31, 2024 18.86 Mn
Sep 30, 2024 22.87 Mn
Jun 30, 2024 21.27 Mn
Mar 31, 2024 17.82 Mn
Dec 31, 2023 19.12 Mn
Sep 30, 2023 11.96 Mn
Jun 30, 2023 31.43 Mn
Mar 31, 2023 18.67 Mn
Dec 31, 2022 19.07 Mn
Sep 30, 2022 17.69 Mn
Dec 31, 2021 20.00 Mn